Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark

Showing results (1141-1150 of 1,377) with videos related to

Pageof 138
Sort By:
Circulation. Cardiovascular Quality and Outcomes|February 3, 2025
Economic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized TrialDerek S Chew, Daniel B Mark, Yanhong Li, et al.
Journal of the American Society of Nephrology : JASN|April 8, 2020
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL TrialIain C Macdougall, Sunil Bhandari, Claire White, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Nature Reviews. Nephrology|December 13, 2018
Author Correction: Lipid management in patients with chronic kidney diseaseCharles J Ferro, Patrick B Mark, Mehmet Kanbay, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Circulation|September 5, 2025
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIAChetan P Huded, John A Spertus, Philip G Jones, et al.
The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|February 28, 2017
Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patientsMatthew P M Graham-Brown, Elaine Rutherford, E Levelt, et al.
Nature Reviews. Nephrology|October 27, 2018
Lipid management in patients with chronic kidney diseaseCharles J Ferro, Patrick B Mark, Mehmet Kanbay, et al.
Pageof 138

Showing results (1141-1150 of 1,377) with videos related to

Sort By:
Pageof 138
Circulation. Cardiovascular Quality and Outcomes|February 3, 2025
Economic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized TrialDerek S Chew, Daniel B Mark, Yanhong Li, et al.
Journal of the American Society of Nephrology : JASN|April 8, 2020
Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL TrialIain C Macdougall, Sunil Bhandari, Claire White, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Nature Reviews. Nephrology|December 13, 2018
Author Correction: Lipid management in patients with chronic kidney diseaseCharles J Ferro, Patrick B Mark, Mehmet Kanbay, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Circulation|September 5, 2025
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIAChetan P Huded, John A Spertus, Philip G Jones, et al.
The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|February 28, 2017
Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patientsMatthew P M Graham-Brown, Elaine Rutherford, E Levelt, et al.
Nature Reviews. Nephrology|October 27, 2018
Lipid management in patients with chronic kidney diseaseCharles J Ferro, Patrick B Mark, Mehmet Kanbay, et al.
Pageof 138